Schrödinger Sees Unusually Large Options Volume (NASDAQ:SDGR)

Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) was the target of unusually large options trading on Friday. Stock traders purchased 11,950 call options on the stock. This is an increase of approximately 1,122% compared to the typical volume of 978 call options.

Schrödinger Stock Performance

SDGR traded down $1.36 on Wednesday, reaching $24.24. 1,222,352 shares of the company's stock were exchanged, compared to its average volume of 816,873. Schrödinger has a twelve month low of $16.60 and a twelve month high of $28.47. The company's 50 day moving average is $21.98 and its 200-day moving average is $20.84. The company has a market cap of $1.77 billion, a price-to-earnings ratio of -10.36 and a beta of 1.77.

Schrödinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The business had revenue of $88.32 million during the quarter, compared to analyst estimates of $83.20 million. Sell-side analysts forecast that Schrödinger will post -2.37 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on SDGR. KeyCorp raised their price objective on Schrödinger from $30.00 to $32.00 and gave the stock an "overweight" rating in a report on Wednesday. Piper Sandler dropped their price objective on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. One analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Buy" and an average target price of $33.00.

Remove Ads

Insider Transactions at Schrödinger

In related news, CFO Geoffrey Craig Porges sold 5,491 shares of Schrödinger stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $21.76, for a total transaction of $119,484.16. Following the completion of the sale, the chief financial officer now owns 27,544 shares in the company, valued at approximately $599,357.44. This trade represents a 16.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Karen Akinsanya sold 16,723 shares of the company's stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $25.09, for a total transaction of $419,580.07. Following the transaction, the insider now directly owns 15,625 shares in the company, valued at $392,031.25. The trade was a 51.70 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 8.60% of the company's stock.

Institutional Trading of Schrödinger

Large investors have recently added to or reduced their stakes in the stock. Point72 Hong Kong Ltd acquired a new position in shares of Schrödinger during the fourth quarter worth about $27,000. Paradigm Asset Management Co. LLC purchased a new stake in shares of Schrödinger during the 4th quarter valued at about $50,000. GAMMA Investing LLC raised its holdings in shares of Schrödinger by 87.5% during the 4th quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock valued at $54,000 after buying an additional 1,305 shares during the period. KBC Group NV lifted its position in Schrödinger by 73.9% during the 4th quarter. KBC Group NV now owns 4,361 shares of the company's stock worth $84,000 after acquiring an additional 1,853 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in Schrödinger in the 4th quarter worth approximately $199,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.